Cargando…
Serum lncRNA-ANRIL and SOX9 expression levels in glioma patients and their relationship with poor prognosis
BACKGROUND: lncRNA-CDKN2B antisense RNA 1 (ANRIL) and SRY-box transcription factor 9 (SOX9) has abnormal expression in many tumors including glioma, but the underlying molecular mechanism is unclear. This study set out to investigate the serum lncRNA-ANRIL and SOX9 levels in glioma patients and thei...
Autores principales: | Sun, Youlu, Jing, Yuesong, Zhang, Yuxin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8461887/ https://www.ncbi.nlm.nih.gov/pubmed/34556140 http://dx.doi.org/10.1186/s12957-021-02392-2 |
Ejemplares similares
-
Upregulation of SOX2-activated lncRNA ANRIL promotes nasopharyngeal carcinoma cell growth
por: Wu, Jian-Hui, et al.
Publicado: (2018) -
Expression and clinical value of lncRNA MALAT1 and lncRNA ANRIL in glaucoma patients
por: Zheng, Miao, et al.
Publicado: (2020) -
The lncRNA ANRIL is down-regulated in peripheral blood of patients with periodontitis
por: Gholami, Leila, et al.
Publicado: (2020) -
Effect of lncRNA ANRIL silencing on anoikis and cell cycle in human glioma via microRNA-203a
por: Dai, Weiying, et al.
Publicado: (2018) -
Downregulation of lncRNA ANRIL suppresses growth and metastasis in human osteosarcoma cells
por: Guan, Hongya, et al.
Publicado: (2018)